Prenatal opiate withdrawal activates the chick embryo hypothalamic-pituitary-adrenal axis and dilates vitelline blood vessels via serotonin2 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 1, 2002, Pages 257-264

  Schrott, Lisa M ^a   Baumgart, Mary Irene ^a   Zhang, Xuewei ^a   Sparber, Sheldon B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; ISOBUTYLMETHYLXANTHINE; NALOXONE; NORACYMETHADOL; OPIATE; PHOSPHODIESTERASE; RITANSERIN; SEROTONIN 2 RECEPTOR;

ARTICLE; CHICK EMBRYO; CORTICOSTERONE BLOOD LEVEL; DRUG WITHDRAWAL; EMBRYO; EMBRYO DEVELOPMENT; HEMODYNAMICS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; OPIATE ADDICTION; PRENATAL PERIOD; PRIORITY JOURNAL; VASODILATATION; YOLK SAC;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CHICK EMBRYO; CORTICOSTERONE; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; METHADYL ACETATE; MORPHOGENESIS; NALOXONE; NARCOTICS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, SEROTONIN; RITANSERIN; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036785472     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037044     Document Type: Article

References (40)

1. Bollweg G, Wei YX, and Sparber SB (1998) Behavioral and neuroendocrine assessment of ritanserin exposure in the developing chicken: lack of toxicity at effective doses. Pharmacol Biochem Behav 60:175-181.
2. Bordone L, Schrott LM, and Sparber SB (1997) Ontogeny of glucocorticoid receptors in the hyperstriatum-hippocampus-parahippocampal area and optic tectum of the embryonic chicken (Gallus domesticus) brain. J Neuroendocrinol 9:753-761.
3. Bronson ME and Sparber SB (1989) Evidence of single dose opioid dependence in 14-day old chicken embryos. Pharmacol Biochem Behav 34:705-709.
4. Buccafusco JJ (1983) Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine. Pharmacol Biochem Behav 18:209-215.
5. Butt NM, Collier HOJ, Cuthbert NJ, Francis DL, and Saeed SA (1979) Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines. Eur J Pharmacol 53:375-378.
6. Cabrera TM, Levy AD, Li Q, Van de Kar LD, and Battaglia G (1994) Cocaine-induced deficits in ACTH and corticosterone responses in female rat progeny. Brain Res Bull 34:93-97.
7. Chan R, Irvine R, and White J (1999) Cardiovascular changes during morphine administration and spontaneous withdrawal in the rat. Eur J Pharmacol 368:25-33.
8. Christie MJ, Williams JT, Osborne PB, and Bellchambers CE (1997) Where is the locus of opioid withdrawal? Trends Pharmacol Sci 18:134-140.
9. Cohen MS, Rudolph AM, and Melmon KL (1980) Antagonism of morphine by naloxone in pregnant ewes and fetal lambs. Dev Pharmacol Ther 1:58-69.
10. Collier HOJ, Cuthbert NJ, and Francis DL (1981) Character and meaning of quasimorphine withdrawal phenomena elicited by methylxanthines. Fed Proc 40:1513-1518.
11. Day JC, Koehl M, Deroche V, Le Moal M, and Maccari S (1998) Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release. J Neurosci 18:1886-1892.
12. Fuller RW (1992) The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol 13:250-270.
13. Grant SJ and Redmond DE (1982) Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome. Pharmacol Biochem Behav 17:655-658.
14. Holtzman SG (1989) Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats. Pharmacol Biochem Behav 33:875-879.
15. Jones KL and Barr GA (2000) Opiate withdrawal in the fetal rat: a behavioral profile. Pharmacol Biochem Behav 66:419-424.
16. Kandall SR, Doberczak TM, Jantunen M, and Stein J (1999) The methadone-maintained pregnancy. Clin Perinatol 26:173-183.
17. Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, and Rubinstein KJ (1992) Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. J Pharmacol Exp Ther 260:355-363.
18. Kirby ML and Holtzman SG (1982) Effects of chronic opiate administration on spontaneous activity of fetal rats. Pharmacol Biochem Behav 16:263-269.
19. Kleven MS and Sparber SB (1989a) Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine. J Pharmacol Exp Ther 248:273-277.
20. Kleven MS and Sparber SB (1989b) Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal. Psychopharmacology 98:231-235.
21. Kuwahara MD and Sparber SB (1981) Continuous exposure of the chick embryo to 1-α-noracetylmethadol does not alter brain protein or nucleic acid content. Dev Pharmacol Ther 3:12-24.
22. 2 receptor mediation. Pharmacol Biochem Behav 69:71-75.
23. Lauder JM and Krebs H (1978) Serotonin as a differentiation signal in early neuroembryogenesis. Dev Neurosci 1:15-30.
24. Little PJ and Kuhn CM (1995) Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis. Psychopharmacology 122:78-84.
25. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, and Laudron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin. Mol Pharmacol 27:600-611.
26. Marin J, Reviriego J, and Fernandez-Alfonso MS (1990) Ability of ketanserin to block different receptors in human placental vessels. J Pharm Pharmacol 42:217-220.
27. Martin GR (1994) Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 62:283-324.
28. Metcalfe J and Stock MK (1993) Current topic: oxygen exchange in the chorioallantoic membrane, avian homologue of the mammalian placenta. Placenta 14:605-613.
29. Mitchell JL (1995) Consensus panel on pregnant, substance abusing women. CSAT-SAMHSA Treatment Improvement Protocol. DHHS Publication No. SMA 95-3056, Department of Health and Human Services, Rockville, MD.
30. Neal BS and Sparber SB (1986) Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J Pharmacol Exp Ther 236:157-165.
31. Neal BS and Sparber SB (1991) Long-term effects of neonatal exposure to isobutylmethylxanthine: I. Retardation of learning with antagonism by mianserin. Psychopharmacology 103:388-397.
32. Pechnick RN (1993) Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol 33:353-382.
33. Romanoff AL (1960) The Avian Embryo, Macmillan, New York.
34. Schrott LM, Sweeney W, Bodensteiner K, and Sparber SB (1999) Ritanserin exposure during late embryogenesis fails to alter the behavioral, febrile and corticosterone response to lipopolysaccharide in young chickens. Pharmacol Biochem Behav 64:81-89.
35. 2) receptors during late development of chicken embryos causes decreased embryonic motility, interferes with hatching and induces herniated umbilici. Pharmacol Biochem Behav 53:603-611.
36. Trueblood B, Judson BA, and Goldstein A (1978) Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts. Drug Alcohol Depend 3:125-132.
37. Umans JG and Szeto HH (1985) Precipitated abstinence in utero. Am J Obstet Gynecol 151:441-444.
38. Zhang X, Schrott LM, and Sparber SB (1998) Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated umbilici in hatchlings. Pharmacol Biochem Behav 59:585-593.
39. Zhang L and Dyer DC (1990) Characterization of serotonergic receptors mediating contraction of ovine umbilical artery. J Pharmacol Exp Ther 255:233-239.
40. Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, and Davis R (1975) Fetal stress from methadone withdrawal. Am J Obstet Gynecol 122:43-46.